Skip to main content
. 2019 Mar 5;90(6):393–406. doi: 10.1159/000496614

Fig. 7.

Fig. 7

Changes in IGF-I, expressed as fold-increase after 12 months of growth hormone (GH) therapy, in different age groups of patients with GH deficiency (GHD; a) or Turner syndrome (TS; b) using needle injection (NI) or needle-free (NF) administration devices. Data are expressed as median and range. * p = 0.014.